22.0405.aF treatment induced statistically significant activation of tumor-resident NK cells, measured as an increased percentage of NK cells expressing CD69 (Figure 5B) or IFN-γ compared to vehicle-treated tumors. The gene discussed is CD69; the disease is neoplasm.